Symbols

Symbols

PTCT

PTCT

PTC Therapeutics Director Reeve Emma Buys and Sells Shares on November 12, 2025.

Ptc Therapeutics's 15min chart shows Bollinger Bands Narrowing, KDJ Death Cross.

Thursday Nov 13, 2025

Ptc Therapeutics 15min chart triggers MACD and KDJ death crosses.

Tuesday Nov 11, 2025

Ptc Therapeutics stock price drops on MACD Death Cross, KDJ Death Cross signal.

Monday Nov 10, 2025

Ptc Therapeutics: MACD Death Cross, Bollinger Bands Narrowing on 15-Minute Chart

Friday Nov 07, 2025

Ptc Therapeutics's 15min chart indicates RSI Overbought, Bollinger Bands Narrowing

Thursday Nov 06, 2025

Ptc Therapeutics: Barclays maintains Equal-Weight, PT raised to $68 from $46.

PTC Therapeutics Sees Stock Surge, Translarna Key to Future Growth

Wednesday Nov 05, 2025

Citi Keeps Neutral on PTC Therapeutics, Raises PT to $75 from $50

Ptc Therapeutics: TD Cowen maintains Hold, PT raised to $63 from $50.

Ptc Therapeutics: RBC Capital Raises PT to $82 from $70, Maintains Outperform

Goldman Sachs Maintains Sell Rating for PTC Therapeutics, Raises PT to $50.

Wells Fargo Upgrades PTC Therapeutics to Overweight, Raises PT to $93.

PTC Therapeutics Narrows 2025 Revenue Guidance to $750M-$800M, Cites Accelerated Sephience Launch

Tuesday Nov 04, 2025

PTC Therapeutics Reports Q3 Earnings: $15.9mln Profit, $211mln Revenue

PTC Therapeutics Q3 Revenue Rises to $211 Million, Reflecting Strong Growth in Rare Diseases Biopharma

PTC Therapeutics Q3 Revenue at $211mln, Full-Year Guidance Narrowed to $750-$800mln.

Friday Oct 31, 2025

PTC THERAPEUTICS: Director Emma sells 12000 shares at $69.5 on Oct 30.

PTC Therapeutics Executives to Speak at Healthcare Conferences in November and December.

Wednesday Oct 29, 2025

Ptc Therapeutics's 15min chart sees MACD Death Cross, KDJ Death Cross signals.